Lirola's Worn and Signed Shirt, Frosinone-Sassuolo

关闭

Ended:Monday 28 January EST 2019 于 12:02

Winner: cipodd74

€150($162 USD)

慈善百分比

80%

错过了？

另一个独特的物品可能就在您身边！

联系我们

慈善百分比

80%

奖品

Take home this black and green U.S. Sassuolo Calcio home shirt worn by Spanish right back Pol Lirola for a match against Frosinone, 16th matchday of the Serie A TIM 2018/19 championship.

The game was played at the Stadio Benito Stirpe in Frosinone on December 16 2018 and ended in a 2-0 win to the visiting side.

To support research into the treatment of rare genetic diseases, the Serie A squads took to the pitch for the 29th Telethon marathon promoted by the Foundation.

Lirola has signed the back of the shirt making it a truly unique collector's item.

Features:

Black and green short-sleeved home shirt
Worn by Pol Lirola
Unwashed
Signed
Sassuolo emblem on chest
Sponsored by Kappa
Serie A TIM patch on right sleeve
Name and number in smooth plastic lettering
Number 21
Size L

Please note: This shirt is unwashed and displays evident signs of use on pitch.

通过拍卖方式购买独特的物品前还需要买家的仔细评估。我们邀请您在购买之前查看您所掌握的所有信息和资料，包括我们的退货政策。

原因

Since 1990, we have been investing in the best research to find cures for rare genetic diseases. Because these diseases are so rare, often times there is no research being done on them, never mind therapeutic options or a cure.

We want to change this state of affairs because we believe that every person is worth fighting for.

We focus on transforming the results of excellent scientific research projects, selected and supported over time, into accessible treatments.

Finding a cure is not the final destination but a new starting point. We have to make every possible effort to guarantee that successful forms of treatment discovered through the research funded by Telethon are then made available to all patients.

For this reason we also work to develop partnerships with public health care institutions and pharmaceutical companies, so that the results of our research will translate to treatment and medicine accessible to all patients worldwide.

网站